Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Robinson

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Clinical Epidemiology|May 21, 2020
Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European CountriesEdith M Heintjes, Irene D Bezemer, Daniel Prieto-Alhambra, et al.
Pharmacoepidemiology and Drug Safety|April 29, 2024
Lessons learned from a multi-data source research collaboration: The mirabegron post-authorization safety study programStefan de Vogel, John D Seeger, Alejandro Arana, et al.
Diabetologia|July 28, 2022
Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation studyJie Zheng, Min Xu, Venexia Walker, et al.
Journal of Patient Safety|March 14, 2020
Defining the Epidemiology of Safety Risks in Neonatal Intensive Care Unit Patients Requiring SurgeryDaniel J France, Jason Slagle, Emma Schremp, et al.
Annals of Surgery|August 14, 2014
Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patientsDavid A Kooby, Neha L Lad, Malcolm H Squires, et al.
Nature Genetics|September 8, 2020
Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseasesJie Zheng, Valeriia Haberland, Denis Baird, et al.
Cell Reports. Medicine|August 21, 2024
The effect of SGLT2 inhibition on prostate cancer: Mendelian randomization and observational analysis using electronic healthcare and cohort dataJie Zheng, Jieli Lu, Jiying Qi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 25, 2023
Lowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and Its Risk Factors: Evidence From a Genome-Wide Association Meta-Analysis Followed by Mendelian RandomizationJie Zheng, Eleanor Wheeler, Maik Pietzner, et al.
International Journal of Epidemiology|January 9, 2022
Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney diseaseJie Zheng, Yuemiao Zhang, Humaira Rasheed, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Clinical Epidemiology|May 21, 2020
Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European CountriesEdith M Heintjes, Irene D Bezemer, Daniel Prieto-Alhambra, et al.
Pharmacoepidemiology and Drug Safety|April 29, 2024
Lessons learned from a multi-data source research collaboration: The mirabegron post-authorization safety study programStefan de Vogel, John D Seeger, Alejandro Arana, et al.
Diabetologia|July 28, 2022
Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation studyJie Zheng, Min Xu, Venexia Walker, et al.
Journal of Patient Safety|March 14, 2020
Defining the Epidemiology of Safety Risks in Neonatal Intensive Care Unit Patients Requiring SurgeryDaniel J France, Jason Slagle, Emma Schremp, et al.
Annals of Surgery|August 14, 2014
Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patientsDavid A Kooby, Neha L Lad, Malcolm H Squires, et al.
Nature Genetics|September 8, 2020
Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseasesJie Zheng, Valeriia Haberland, Denis Baird, et al.
Cell Reports. Medicine|August 21, 2024
The effect of SGLT2 inhibition on prostate cancer: Mendelian randomization and observational analysis using electronic healthcare and cohort dataJie Zheng, Jieli Lu, Jiying Qi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 25, 2023
Lowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and Its Risk Factors: Evidence From a Genome-Wide Association Meta-Analysis Followed by Mendelian RandomizationJie Zheng, Eleanor Wheeler, Maik Pietzner, et al.
International Journal of Epidemiology|January 9, 2022
Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney diseaseJie Zheng, Yuemiao Zhang, Humaira Rasheed, et al.
Pageof 5